Gemcitabine resistance in triple‑negative breast cancer cells can be reverted by <em>Drosophila melanogaster</em> deoxyribonucleoside kinase in the nucleus or cytosol

Yan Zhao(Harbin Institute of Technology), Xinyu Zheng(Xuzhou Medical College)
Oncology Letters
September 15, 2020
Cited by 8


Related Papers